December 9-13, 2014 | San Antonio TX, USA | SABCS

 

 

 

The San Antonio Breast Cancer Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. 

 

Jean-Gabriel JUDDE – President & CSO and Stefano CAIRO – Lab Head H&D and Bioinformatics will present a poster in partnership with TESARO and Myriad Genetics.

 

 

Poster #858  : The PRAP inhibitor niraparib demonstrates activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score.